Yoshiji et al. reported that this ACE inhibitor considerably inhibited tumor growth and angiogenesis in hepatocellular carcinoma cells, along with suppression of the vascular endothelial growth factor (VEGF) level [156]. The gene discussed is VEGFA; the disease is neoplasm.